Education
About Us
Working with TipRanks
Follow Us
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
NASDAQ:SHPH
RESEARCH TOOLSreports
Total Valuation
Shuttle Pharmaceuticals Holdings, Inc. has a market cap or net worth of $1.46M. The enterprise value is $154.64M.
Market Cap$1.46M
Enterprise Value$154.64M
Share Statistics
Shuttle Pharmaceuticals Holdings, Inc. has 10,984,291 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,984,291
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shuttle Pharmaceuticals Holdings, Inc.’s return on equity (ROE) is -12.90 and return on invested capital (ROIC) is -368.06%.
Return on Equity (ROE)-12.90
Return on Assets (ROA)-3.65K
Return on Invested Capital (ROIC)-368.06%
Return on Capital Employed (ROCE)5.03
Revenue Per Employee0.00
Profits Per Employee-1.02M
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Shuttle Pharmaceuticals Holdings, Inc. is >-0.01. Shuttle Pharmaceuticals Holdings, Inc.’s PEG ratio is -0.22.
PE Ratio>-0.01
PS Ratio0.00
PB Ratio21.14
Price to Fair Value<0.01
Price to FCF-59.88
Price to Operating Cash Flow-59.88
PEG Ratio-0.22
Income Statement
In the last 12 months, Shuttle Pharmaceuticals Holdings, Inc. had revenue of 0.00 and earned -9.14B in profits. Earnings per share was -3.19K.
Revenue0.00
Gross Profit0.00
Operating Income-7.70B
Pretax Income-9.14B
Net Income-9.14B
EBITDA-7.70B
Earnings Per Share (EPS)-3.19K
Cash Flow
In the last 12 months, operating cash flow was -8.62M and capital expenditures 0.00, giving a free cash flow of -8.62M billion.
Operating Cash Flow-8.62M
Free Cash Flow-8.62M
Free Cash Flow per Share-0.78
Dividends & Yields
Shuttle Pharmaceuticals Holdings, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.44
52-Week Price Change-96.07%
50-Day Moving Average0.25
200-Day Moving Average0.79
Relative Strength Index (RSI)29.58
Average Volume (3m)10.04M
Important Dates
Shuttle Pharmaceuticals Holdings, Inc. upcoming earnings date is Sep 4, 2024, TBA Not Confirmed.
Last Earnings DateMay 14, 2024
Next Earnings DateSep 4, 2024
Ex-Dividend Date―
Financial Position
Shuttle Pharmaceuticals Holdings, Inc. as a current ratio of 1.44, with Debt / Equity ratio of 9.75%
Current Ratio1.44
Quick Ratio1.44
Debt to Market Cap573.33
Net Debt to EBITDA<0.01
Interest Coverage Ratio-5.66K
Taxes
In the past 12 months, Shuttle Pharmaceuticals Holdings, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Shuttle Pharmaceuticals Holdings, Inc. EV to EBITDA ratio is >-0.01, with an EV/FCF ratio of -0.23.
EV to Sales0.00
EV to EBITDA>-0.01
EV to Free Cash Flow-0.23
EV to Operating Cash Flow-0.23
Balance Sheet
Shuttle Pharmaceuticals Holdings, Inc. has $4.51M in cash and marketable securities with $1.10M in debt, giving a net cash position of -$3.41M billion.
Cash & Marketable Securities$4.51M
Total Debt$1.10M
Net Cash-$3.41M
Net Cash Per Share-$0.31
Tangible Book Value Per Share$0.25
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Shuttle Pharmaceuticals Holdings, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-7.18%